Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2017 | ImMAGE Biotherapeutics Announces Termination of Operations | CI |
2017 | ImMAGE Biotherapeutics Initiates Repeat Toxicology Study for Lead Candidate, IMT-001 | CI |
Sales 2015 | - | Sales 2016 | - | Capitalization | 46.08M 3.66B |
---|---|---|---|---|---|
Net income 2015 | - 0 | Net income 2016 | - 0 | EV / Sales 2015 * | - |
Net Debt 2015 | 15.23K 1.21M | Net cash position 2016 | 144K 11.45M | EV / Sales 2016 | - |
P/E ratio 2015 * |
-
| P/E ratio 2016 |
-211
x | Employees | 4 |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 30.14% |
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Narayanan
FOU | Founder | 35 | 20/06/12 |
Anton Dormer
FOU | Founder | 60 | 20/06/12 |
Zhi Cong Mou
CEO | Chief Executive Officer | 41 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Cong Mou
CEO | Chief Executive Officer | 41 | - |
Elton Norman
DFI | Director of Finance/CFO | 61 | - |
Anton Dormer
FOU | Founder | 60 | 20/06/12 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 151 | |
+6.05% | 105B | |
-4.43% | 64.68B | |
+53.33% | 43.21B | |
+17.94% | 39.33B | |
+6.93% | 32.99B | |
+11.62% | 20.09B | |
+14.15% | 17.05B | |
+24.53% | 15.96B | |
+7.25% | 14.69B |
- Stock Market
- Equities
- IMMG Stock